We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENG
11776
CALL
DELISTED
ENGlobal Corp
ENG
$55K ﹤0.01%
7,238
-2,037
-22% -$18.6K
BCEL
11777
CALL
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$55K ﹤0.01%
30,600
-20,000
-40% -$41.8K
TRHC
11778
CALL
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$55K ﹤0.01%
21,300
+5,600
+36% +$21K
CLVR
11779
PUT
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$55K ﹤0.01%
1,877
-2,083
-53% -$83.2K
OIG
11780
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$55K ﹤0.01%
+2,208
New +$97.9K
FVIV.WS
11781
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$55K ﹤0.01%
294,504
-18,092
-6% -$6.75K
BKEP
11782
CALL
DELISTED
Blueknight Energy Partners L.P.
BKEP
$55K ﹤0.01%
12,100
-10,600
-47% -$45.1K
EVFM
11783
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$55K ﹤0.01%
48,420
+46,220
+2,101% +$76.2K
BBAR icon
11784
CALL
BBVA Argentina
BBAR
$3.13B
$54K ﹤0.01%
22,800
+9,300
+69% +$27.6K
BCLI
11785
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$54K ﹤0.01%
1,293
-534
-29% -$24K
BZFD icon
11786
CALL
BuzzFeed
BZFD
$92.5M
$54K ﹤0.01%
8,825
-2,975
-25% -$44.9K
EPIX
11787
CALL
DELISTED
ESSA Pharma
EPIX
$54K ﹤0.01%
17,100
-4,500
-21% -$25.1K
OKYO
11788
OKYO Pharma
OKYO
$79.8M
$54K ﹤0.01%
+26,864
New +$60.4K
RAVE icon
11789
RAVE Restaurant Group
RAVE
$43.2M
$54K ﹤0.01%
+49,735
New +$49.3K
RGS icon
11790
CALL
Regis Corp
RGS
$69.3M
$54K ﹤0.01%
2,520
-110
-4% -$2.48K
THMO
11791
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$54K ﹤0.01%
+4,338
New +$85.5K
VINO
11792
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$54K ﹤0.01%
+74
New +$121K
VELOW
11793
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$54K ﹤0.01%
536,030
-102,036
-16% -$20.6K
AUTL
11794
CALL
Autolus Therapeutics
AUTL
$572M
$53K ﹤0.01%
+18,600
New +$56.6K
FLUX icon
11795
Flux Power
FLUX
$12.7M
$53K ﹤0.01%
22,289
-10,272
-32% -$25.4K
KPLT icon
11796
PUT
Katapult Holdings
KPLT
$36.7M
$53K ﹤0.01%
1,968
-2,520
-56% -$99.7K
ROIV icon
11797
CALL
Roivant Sciences
ROIV
$26.1B
$53K ﹤0.01%
+12,900
New +$51.2K
TNON icon
11798
Tenon Medical
TNON
$2.56M
$53K ﹤0.01%
+8
New +$233K
VNRX icon
11799
VolitionRx Ltd
VNRX
$6.89M
$53K ﹤0.01%
1,284
-23
-2% -$1.16K
IRD
11800
CALL
Opus Genetics
IRD
$300M
$53K ﹤0.01%
27,600
-5,400
-16% -$12.3K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.